🇺🇸 FDA
Patent

US 9890176

Mannose derivatives for treating bacterial infections

granted A61PA61P1/04A61P13/02

Quick answer

US patent 9890176 (Mannose derivatives for treating bacterial infections) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P1/04, A61P13/02, A61P31/04